Sony To Pay $640 Million To Control Olympus, Merge Medical Device Work
This article was originally published in PharmAsia News
Executive Summary
Sony and Olympus have agreed to a merger, with Sony buying control with a $640 million investment to focus on medical devices such as endoscopes and surgical products drawing on the buyer's technology.
Sony and Olympus have agreed to a merger, with Sony buying control with a $640 million investment to focus on medical devices such as endoscopes and surgical products drawing on the buyer's technology. The agreement between the two Japanese companies calls for Sony to buy 11% of the shares of Olympus, which has been troubled by accounting scandals. Sony aims for the merged company to gain a 20% share of the global market in surgery devices by 2020. (Click here for more
)
"Sony-Olympus Alliance Aims For High-Tech Surgery" - New York Times (9/30/2012)